Annuncio • Feb 27
NFC Public Company Limited, Annual General Meeting, Apr 28, 2026 NFC Public Company Limited, Annual General Meeting, Apr 28, 2026, at 14:00 SE Asia Standard Time. Location: physical meeting, the academy meeting room, 2nd floor, sc group building, 88 the parkland road, bangna nuea, bang na, bangkok Thailand New Risk • Jun 04
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Thai stocks, typically moving 6.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.3x net interest cover). Minor Risks Share price has been volatile over the past 3 months (6.2% average weekly change). Profit margins are more than 30% lower than last year (2.2% net profit margin). Market cap is less than US$100m (฿1.93b market cap, or US$58.8m). Buy Or Sell Opportunity • Jun 04
Now 41% undervalued after recent price drop Over the last 90 days, the stock has fallen 9.6% to ฿1.23. The fair value is estimated to be ฿2.08, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 7.7% over the last 3 years. Earnings per share has declined by 51%. Reported Earnings • May 16
First quarter 2025 earnings released: EPS: ฿0.012 (vs ฿0.01 in 1Q 2024) First quarter 2025 results: EPS: ฿0.012 (up from ฿0.01 in 1Q 2024). Revenue: ฿541.4m (up 28% from 1Q 2024). Net income: ฿13.1m (up 21% from 1Q 2024). Profit margin: 2.4% (down from 2.6% in 1Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 51% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings. Buy Or Sell Opportunity • Apr 04
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 14% to ฿1.45. The fair value is estimated to be ฿1.84, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 45%. Annuncio • Apr 02
NFC Public Company Limited Announces CFO Changes NFC Public Company Limited announced the termination of Miss Vipapun Datnuntarat as Chief Accountant, Effective Date of Termination of 14 March 2025. The company appointed Miss Dudduen Boonsue as Chief Financial Officer, Effective Date of Appointment of 15 March 2025. Annuncio • Feb 27
NFC Public Company Limited, Annual General Meeting, Apr 29, 2025 NFC Public Company Limited, Annual General Meeting, Apr 29, 2025, at 14:00 SE Asia Standard Time. New Risk • Feb 27
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 2.2% Last year net profit margin: 10% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.2x net interest cover). Minor Risks Profit margins are more than 30% lower than last year (2.2% net profit margin). Market cap is less than US$100m (฿1.49b market cap, or US$44.0m). Reported Earnings • Feb 27
Full year 2024 earnings released: EPS: ฿0.038 (vs ฿0.17 in FY 2023) Full year 2024 results: EPS: ฿0.038 (down from ฿0.17 in FY 2023). Revenue: ฿1.89b (up 4.7% from FY 2023). Net income: ฿41.9m (down 77% from FY 2023). Profit margin: 2.2% (down from 10.0% in FY 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 45% per year but the company’s share price has only fallen by 28% per year, which means it has not declined as severely as earnings. Reported Earnings • Nov 15
Third quarter 2024 earnings released: EPS: ฿0.019 (vs ฿0.023 in 3Q 2023) Third quarter 2024 results: EPS: ฿0.019 (down from ฿0.023 in 3Q 2023). Revenue: ฿510.3m (up 36% from 3Q 2023). Net income: ฿20.8m (down 16% from 3Q 2023). Profit margin: 4.1% (down from 6.6% in 3Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 21% per year whereas the company’s share price has fallen by 22% per year. Valuation Update With 7 Day Price Move • Sep 12
Investor sentiment deteriorates as stock falls 26% After last week's 26% share price decline to ฿2.44, the stock trades at a trailing P/E ratio of 16.1x. Average trailing P/E is 14x in the Chemicals industry in Thailand. Total loss to shareholders of 38% over the past three years. Valuation Update With 7 Day Price Move • Aug 27
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ฿1.40, the stock trades at a trailing P/E ratio of 9.3x. Average trailing P/E is 14x in the Chemicals industry in Thailand. Total loss to shareholders of 64% over the past three years. Reported Earnings • Aug 14
Second quarter 2024 earnings released: EPS: ฿0.01 (vs ฿0.017 in 2Q 2023) Second quarter 2024 results: EPS: ฿0.01 (down from ฿0.017 in 2Q 2023). Revenue: ฿446.6m (up 26% from 2Q 2023). Net income: ฿10.5m (down 44% from 2Q 2023). Profit margin: 2.4% (down from 5.3% in 2Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has fallen by 32% per year, which means it is performing significantly worse than earnings. New Risk • Aug 02
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Thai stocks, typically moving 9.8% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.5x net interest cover). Share price has been highly volatile over the past 3 months (9.8% average weekly change). Minor Risk Market cap is less than US$100m (฿1.41b market cap, or US$40.0m). Buy Or Sell Opportunity • Aug 02
Now 27% undervalued after recent price drop Over the last 90 days, the stock has fallen 54% to ฿1.30. The fair value is estimated to be ฿1.77, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 23% over the last 3 years. Earnings per share has grown by 10%. Valuation Update With 7 Day Price Move • Aug 02
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to ฿1.46, the stock trades at a trailing P/E ratio of 9.2x. Average trailing P/E is 13x in the Chemicals industry in Thailand. Total loss to shareholders of 62% over the past three years. Buy Or Sell Opportunity • Jul 15
Now 20% overvalued Over the last 90 days, the stock has fallen 40% to ฿1.87. The fair value is estimated to be ฿1.56, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 23% over the last 3 years. Earnings per share has grown by 10%. New Risk • Jun 05
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Thai stocks, typically moving 8.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.5x net interest cover). Minor Risks Share price has been volatile over the past 3 months (8.4% average weekly change). Market cap is less than US$100m (฿2.31b market cap, or US$62.8m). Valuation Update With 7 Day Price Move • Jun 05
Investor sentiment deteriorates as stock falls 25% After last week's 25% share price decline to ฿2.12, the stock trades at a trailing P/E ratio of 13.3x. Average trailing P/E is 17x in the Chemicals industry in Thailand. Total loss to shareholders of 46% over the past three years. Reported Earnings • May 16
First quarter 2024 earnings released: EPS: ฿0.01 (vs ฿0.017 in 1Q 2023) First quarter 2024 results: EPS: ฿0.01 (down from ฿0.017 in 1Q 2023). Revenue: ฿422.3m (flat on 1Q 2023). Net income: ฿10.9m (down 43% from 1Q 2023). Profit margin: 2.6% (down from 4.5% in 1Q 2023). Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings. Reported Earnings • Mar 01
Full year 2023 earnings released: EPS: ฿0.17 (vs ฿0.14 in FY 2022) Full year 2023 results: EPS: ฿0.17 (up from ฿0.14 in FY 2022). Revenue: ฿1.80b (down 34% from FY 2022). Net income: ฿181.0m (up 20% from FY 2022). Profit margin: 10.0% (up from 5.5% in FY 2022). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings. Annuncio • Feb 29
NFC Public Company Limited Proposes to Approve the Omission of Dividend Payment for the Period from 1 January 2023 to 31 December 2023 NFC Public Company Limited at its board meeting held on 27 February 2024 approved to propose to the Annual General Meeting of Shareholders to consider and approve the omission of dividend payment for the operation result of the Company for the year 2023, from 1 January 2023 to 31 December 2023, since the Company needs to reserve for working capital. Annuncio • Feb 28
NFC Public Company Limited, Annual General Meeting, Apr 29, 2024 NFC Public Company Limited, Annual General Meeting, Apr 29, 2024, at 14:00 SE Asia Standard Time. Agenda: To acknowledge the operating performance of the Company for the year 2023; To consider and approve the statements of financial position and comprehensive income statement for the year ended 2023 ended on 31 December 2023; to consider and approve the allocation of the net profit for the year 2023 as legal reserve,and the omission of dividend payment for the operation result of the Company for the year 2023;to consider and approve the appointment of directors replacing those retired by rotation;to consider and approve the remuneration of directors for the year 2024;to consider and approve the appointment of auditor and the remuneration of the auditor for the year 2024; to consider other matters. New Risk • Dec 12
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Thai stocks, typically moving 6.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.5x net interest cover). Minor Risks Dividend is not well covered by earnings (156% payout ratio). Share price has been volatile over the past 3 months (6.1% average weekly change). Profit margins are more than 30% lower than last year (7.2% net profit margin). Reported Earnings • Nov 15
Third quarter 2023 earnings released: EPS: ฿0.023 (vs ฿0.043 in 3Q 2022) Third quarter 2023 results: EPS: ฿0.023 (down from ฿0.043 in 3Q 2022). Revenue: ฿375.5m (down 54% from 3Q 2022). Net income: ฿24.9m (down 47% from 3Q 2022). Profit margin: 6.6% (up from 5.8% in 3Q 2022). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 45% per year but the company’s share price has only increased by 29% per year, which means it is significantly lagging earnings growth. New Risk • Oct 30
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: ฿3.35b (US$93.2m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.8x net interest cover). Minor Risks Dividend is not well covered by earnings (132% payout ratio). Profit margins are more than 30% lower than last year (6.8% net profit margin). Market cap is less than US$100m (฿3.35b market cap, or US$93.2m). Reported Earnings • Aug 09
Second quarter 2023 earnings released: EPS: ฿0.017 (vs ฿0.028 in 2Q 2022) Second quarter 2023 results: EPS: ฿0.017 (down from ฿0.028 in 2Q 2022). Revenue: ฿355.5m (down 47% from 2Q 2022). Net income: ฿18.9m (down 39% from 2Q 2022). Profit margin: 5.3% (up from 4.6% in 2Q 2022). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 68% per year but the company’s share price has only increased by 36% per year, which means it is significantly lagging earnings growth. Upcoming Dividend • May 02
Upcoming dividend of ฿0.18 per share at 3.8% yield Eligible shareholders must have bought the stock before 09 May 2023. Payment date: 26 May 2023. Trailing yield: 3.8%. Lower than top quartile of Thai dividend payers (6.2%). Higher than average of industry peers (3.0%). Valuation Update With 7 Day Price Move • Mar 14
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ฿4.28, the stock trades at a trailing P/E ratio of 31x. Average trailing P/E is 15x in the Chemicals industry in Thailand. Total returns to shareholders of 199% over the past three years. Board Change • Feb 04
Less than half of directors are independent There are 5 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 4 independent directors. 5 non-independent directors. Independent Director Kurujit Nakornthap was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Valuation Update With 7 Day Price Move • Dec 21
Investor sentiment deteriorated over the past week After last week's 16% share price decline to ฿5.05, the stock trades at a trailing P/E ratio of 13x. Average trailing P/E is 17x in the Chemicals industry in Thailand. Total returns to shareholders of 148% over the past three years. Board Change • Nov 16
Less than half of directors are independent There are 5 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 4 independent directors. 5 non-independent directors. Independent Director Kurujit Nakornthap was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Valuation Update With 7 Day Price Move • Nov 10
Investor sentiment improved over the past week After last week's 26% share price gain to ฿7.00, the stock trades at a trailing P/E ratio of 20.1x. Average trailing P/E is 16x in the Chemicals industry in Thailand. Total returns to shareholders of 202% over the past three years. Valuation Update With 7 Day Price Move • Aug 17
Investor sentiment improved over the past week After last week's 68% share price gain to ฿7.95, the stock trades at a trailing P/E ratio of 22.8x. Average trailing P/E is 17x in the Chemicals industry in Thailand. Total returns to shareholders of 120% over the past three years. Reported Earnings • Aug 12
Second quarter 2022 earnings released: EPS: ฿0.028 (vs ฿0.004 in 2Q 2021) Second quarter 2022 results: EPS: ฿0.028 (up from ฿0.004 in 2Q 2021). Revenue: ฿670.0m (up 116% from 2Q 2021). Net income: ฿30.9m (up ฿26.5m from 2Q 2021). Profit margin: 4.6% (up from 1.4% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 127% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth. Annuncio • Aug 11
NFC Public Company Limited Approves Appointment of Kurujit Nakornthap as Independent Director, Audit Committee, Nomination and Remuneration Committee, Effective September 1, 2022 NFC Public Company Limited announced that at the Board of Directors' Meeting of No. 4/2022, held on August 10, 2022 resolved approving the appointment Dr. Kurujit Nakornthap as Independent Director, Audit Committee, Nomination and Remuneration Committee, effective on September 1, 2022. Since September 1, 2022, The Audit Committee will consist of 3 directors as follows: Mr. Virasak Sutanthavibul, Mrs. Aree Termwattanapakdee and Dr. Kurujit Nakornthap. Valuation Update With 7 Day Price Move • Jul 25
Investor sentiment improved over the past week After last week's 19% share price gain to ฿5.70, the stock trades at a trailing P/E ratio of 17.6x. Average trailing P/E is 17x in the Chemicals industry in Thailand. Total returns to shareholders of 43% over the past three years. Annuncio • Jul 13
NFC Public Company Limited Announces Resignation of Seri Wongmonta, Director, Audit Committee and Nomination and Remuneration Committee, Effective July 31, 2022 NFC Public Company Limited informed that Associate Prof. Dr. Seri Wongmonta has submitted his resignation letter to the Company to resign from the position of Director, Audit Committee and Nomination andRemuneration Committee due to his personal business engagement with the effective date on July 31, 2022 onwards. Valuation Update With 7 Day Price Move • Jun 30
Investor sentiment deteriorated over the past week After last week's 15% share price decline to ฿6.40, the stock trades at a trailing P/E ratio of 19.7x. Average trailing P/E is 17x in the Chemicals industry in Thailand. Total returns to shareholders of 73% over the past three years. Annuncio • Jun 29
NFC Public Company Limited Appoints Dudduen Boonsue as Chief Financial Officer, Effective 1 July 2022 NFC Public Company Limited appointed the appointment of Miss Dudduen Boonsue as chief financial officer of the company. Effective date of appointment is on 1 July 2022. Valuation Update With 7 Day Price Move • Jun 07
Investor sentiment improved over the past week After last week's 35% share price gain to ฿3.64, the stock trades at a trailing P/E ratio of 11.2x. Average trailing P/E is 14x in the Chemicals industry in Thailand. Total loss to shareholders of 3.2% over the past three years. Annuncio • Jun 03
NFC Public Company Limited Announces Executive Changes NFC Public Company Limited announced termination of Banchuen Wanarat as Chief Accountant. Position of Chief Accountant: Budgeting & Project Management Division Manager. Effective Date of Termination is May 31, 2022 and appointment of Puricha Sutthisit as Chief Accountant. Effective Date of Appointment is June 1, 2022. Position of Chief Accountant: Accounting Division Manager. Board Change • Apr 27
Less than half of directors are independent There is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 10 experienced directors. No highly experienced directors. 3 independent directors (8 non-independent directors). Independent Director Virasak Sutanthavibul was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Reported Earnings • Feb 27
Full year 2021 earnings: Revenues in line with analyst expectations Full year 2021 results: Revenue: ฿1.36b (up 90% from FY 2020). Net income: ฿352.9m (up ฿361.7m from FY 2020). Profit margin: 26% (up from net loss in FY 2020). The move to profitability was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has fallen by 16% per year, which means it is performing significantly worse than earnings. Reported Earnings • Nov 10
Third quarter 2021 earnings released: EPS ฿0.009 (vs ฿0.005 in 3Q 2020) The company reported a decent third quarter result with improved revenues, although earnings and profit margins were weaker. Third quarter 2021 results: Revenue: ฿380.7m (up 137% from 3Q 2020). Net income: ฿4.15m (down 21% from 3Q 2020). Profit margin: 1.1% (down from 3.3% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 59% per year but the company’s share price has only fallen by 30% per year, which means it has not declined as severely as earnings. Executive Departure • Oct 12
Company Secretary & Office of the Board of Directors Department Manager Chaiyuth Promkird has left the company On the 1st of October, Chaiyuth Promkird's tenure as Company Secretary & Office of the Board of Directors Department Manager ended after 1.4 years in the role. We don't have any record of a personal shareholding under Chaiyuth's name. A total of 2 executives have left over the last 12 months. The current median tenure of the management team is 1.75 years, which is considered inexperienced in the Simply Wall St Risk Model. Executive Departure • Oct 06
Chief Operating Officer Pongpipat Pringsakul has left the company On the 1st of October, Pongpipat Pringsakul's tenure as Chief Operating Officer ended after less than a year in the role. We don't have any record of a personal shareholding under Pongpipat's name. Pongpipat is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 1.75 years, which is considered inexperienced in the Simply Wall St Risk Model. Annuncio • Apr 29
NFC Public Company Limited Approves Omission of Dividend for the Year 2020 NFC Public Company Limited at its AGM held April 28, 2021, approved the appropriation of the net profit for the year 2020 of THB 1.83 million, as legal reserve, and the omission of dividend for the operation result of the company for the year 2020. Annuncio • Mar 06
NFC Public Company Limited, Annual General Meeting, Apr 28, 2021 NFC Public Company Limited, Annual General Meeting, Apr 28, 2021, at 02:30 Coordinated Universal Time. Location: Meeting Room 6th Floor, SC Group Building No. 88 The Park Land Road,Bangna Nuea Sub-District, Bangna District Bangkok Thailand Agenda: To consider and approve the minutes of the extraordinary general meeting of shareholders no. 1/2020 held on 19 October 2020; to consider acknowledge the operational result of the Company for the year 2020; to consider and approve the statements of financial position and the profit and loss statement the Company for the year ended 2020 ended on 31 December 2020; to consider and approve the allocation of the net profit for the year 2020 as legal reserve, and the omission of dividend payment for the operation result of the Company for the year 2020; to consider and appoint the directors in replacement of 4 retiring directors by rotation; to consider the appointment of auditors for the year 2021 and the remuneration for the auditors; and to consider other matters. Reported Earnings • Feb 24
Full year 2020 earnings released: ฿0.008 loss per share (vs ฿0.032 loss in FY 2019) The company reported a decent full year result with reduced losses and improved control over expenses, although revenues were weaker. Full year 2020 results: Revenue: ฿719.3m (down 39% from FY 2019). Net loss: ฿8.76m (loss narrowed 75% from FY 2019). Is New 90 Day High Low • Nov 20
New 90-day high: ฿1.83 The company is up 15% from its price of ฿1.59 on 21 August 2020. The Thai market is up 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 13% over the same period. Reported Earnings • Nov 11
Third quarter 2020 earnings released: EPS ฿0.005 The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2020 results: Revenue: ฿160.5m (down 39% from 3Q 2019). Net income: ฿5.28m (up ฿49.6m from 3Q 2019). Profit margin: 3.3% (up from net loss in 3Q 2019). The move to profitability was driven by lower expenses. Is New 90 Day High Low • Oct 20
New 90-day low: ฿1.40 The company is down 20% from its price of ฿1.75 on 22 July 2020. The Thai market is down 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is down 16% over the same period. Annuncio • Sep 19
Teerawat Wongchareonsin acquired 7.91% stake in NFC Public Company Limited from Pittayakorn Naothaworn. Teerawat Wongchareonsin acquired 7.91% stake in NFC Public Company Limited from Pittayakorn Naothaworn on February 19, 2018. As per the transaction, Teerawat Wongchareonsin acquired 86 million shares. Post completion, Pittayakorn Naothaworn held 98.6 million shares representing 9.06% stake of NFC Public Company Limited.
Teerawat Wongchareonsin completed the acquisition of 7.91% stake in NFC Public Company Limited from Pittayakorn Naothaworn on February 19, 2018.